CD44 Protein

CD44 Protein

Pathway Diagram

```mermaid
flowchart TD
CD4["CD4<br/>T-helper cell receptor"]

CD4 -->|"regulates"| Neurodegeneration["Neurodegeneration<br/>Process"]
CD4 -->|"activates"| MS["Multiple Sclerosis<br/>Autoimmune demyelination"]
CD4 -->|"inhibits"| ALS["Amyotrophic Lateral Sclerosis<br/>Motor neuron disease"]
CD4 -->|"regulates"| PD["Parkinson's Disease<br/>Dopaminergic degeneration"]
CD4 -->|"regulates"| Dementia["Dementia<br/>Cognitive decline"]

CD4 -->|"regulates"| Inflammation["Neuroinflammation<br/>Immune activation"]
CD4 -->|"regulates"| Autoimmune["Autoimmune Response<br/>Self-reactive immunity"]

Inflammation -->|"promotes"| Neurodegeneration
Inflammation -->|"contributes_to"| MS
Inflammation -->|"damages"| PD

Autoimmune -->|"drives"| MS
Autoimmune -->|"influences"| Neurodegeneration

CD4 -->|"activates"| Aging["Cellular Aging<br/>Senescence processes"]
Aging -->|"accelerates"| Neurodegeneration
Aging -->|"increases_risk"| Dementia

CD4 -->|"therapeutic_target"| MS_Treatment["MS Therapeutics<br/>Immunomodulation"]
CD4 -->|"therapeutic_target"| Neuro_Treatment["Neurodegeneration<br/>Therapeutics"]
CD4 -->|"biomarker_for"| ALS_Diagnosis["ALS Biomarker<br/>Disease monitoring"]

style CD4 fill:#006494
style MS_Treatment fill:#1b5e20
style Neuro_Treatment fill:#1b5e20
style ALS_Diagnosis fill:#1b5e20
style MS fill:#ef5350
style ALS fill:#ef5350
style Neurodegeneration fill:#ef5350
style Inflammation fill:#ef5350
st

CD44 Protein

Pathway Diagram

Introduction

Cd44 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background-color: #4a90d9; color: white;">CD44 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Cell Surface Glycoprotein CD44</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>CD44</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>P16070</td></tr>
<tr><td><strong>Protein Length</strong></td><td>341 amino acids (standard isoform)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~80-95 kDa (variable by isoform)</td></tr>
<tr><td><strong>Cellular Location</strong></td><td>Plasma membrane (type I transmembrane)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Immunoglobulin superfamily</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">446 edges</a></td>
</tr>
</table>
</div>

Overview

CD44 is a cell surface glycoprotein involved in cell-cell interactions, cell adhesion, and migration. It exists in multiple isoforms generated by alternative splicing and plays important roles in immune cell trafficking, synaptic plasticity, and neuroinflammation[@aruffo1990]. CD44 serves as the primary receptor for hyaluronic acid (HA), a key component of the extracellular matrix, and mediates numerous cell-matrix and cell-cell interactions critical for development, immune surveillance, and tissue homeostasis[@ponta2003].

Structure

Domain Organization

The CD44 protein contains several distinct structural domains:

• Signal peptide (1-20 aa): N-terminal signal sequence for secretion
• N-terminal hyaluronan-binding domain (21-132 aa): Contains the Link module homologous to cartilage link protein
• Link protein homology module (133-175 aa): Stabilizes HA binding
• Variable region (176-310 aa): Subject to extensive alternative splicing
• Transmembrane domain (311-335 aa): Single-pass membrane-spanning helix
• Cytoplasmic tail (336-341 aa): Interacts with the actin cytoskeleton and signaling proteins[@tartour2011]

Isoforms

CD44 exhibits remarkable molecular diversity through alternative splicing of the variable region. Over 20 isoforms have been described[@hou2019]:

| Isoform | Description | Expression | Function |
|---------|-------------|------------|----------|
| CD44s | Standard isoform (no variant exons) | Ubiquitous | Basic adhesion, hematopoietic cells |
| CD44v3 | Contains v3 exon | Activated leukocytes, endothelium | Binds growth factors (FGF, VEGF) |
| CD44v6 | Contains v6 exon | Tumor cells, activated T cells | Metastasis, T cell activation |
| CD44v8-10 | Contains v8-v10 exons | Epithelial cells, neurons | Protection against oxidative stress |
| CD44v9 | Contains v9 exon | Tumor cells, activated [microglia](/cell-types/microglia-neuroinflammation) | Tumor progression, synaptic plasticity |

Normal Function

Hyaluronic Acid Binding

CD44's primary ligand is hyaluronic acid (HA), a glycosaminoglycan abundant in the extracellular matrix and cerebrospinal fluid[@jiang2011]. The interaction between CD44 and HA:

• Mediates cell adhesion to the extracellular matrix
• Regulates cell migration and tissue architecture
• Influences cell survival and proliferation
• Modulates synaptic structure and plasticity in the brain[@kochlamazashvili2010]

Signaling Functions

CD44 functions as a signaling receptor that activates multiple intracellular pathways:

• ERK/MAPK pathway: Activation of Ras/Raf/MEK/ERK cascade promotes cell proliferation[@cho2011]
• PI3K/Akt pathway: Mediates cell survival and resistance to [apoptosis](/entities/apoptosis)
• Rho GTPases: Regulates cytoskeletal dynamics and cell migration
• [NF-κB](/entities/nf-kb) pathway: Controls inflammatory gene expression[@matzke2007]

Immune Cell Trafficking

CD44 is critical for lymphocyte homing and immune cell trafficking:

• Naive T cell homing: CD44 mediates initial tethering and rolling on vascular endothelium[@degrendele1997]
• Memory T cell recruitment: Upregulated CD44 enables rapid recall responses
• Monocyte/macrophage migration: CD44-HA interactions facilitate tissue infiltration
• Dendritic cell navigation: Essential for antigen-presenting cell migration to lymph nodes[@friedl2000]

Expression Pattern

Brain Expression

In the central nervous system, CD44 is expressed on multiple cell types[@moretto2006]:

| Cell Type | Expression Level | Function |
|-----------|------------------|----------|
| [Microglia](/entities/microglia) | High | Phagocytosis, neuroinflammation |
| [Astrocytes](/entities/astrocytes) | Moderate | Matrix maintenance, scar formation |
| [Neurons](/entities/neurons) | Low-Medium | Synaptic plasticity, memory formation |
| Oligodendrocytes | Low | Myelin maintenance |
| Endothelial cells | High | BBB integrity, leukocyte trafficking |

Peripheral Expression

• Hematopoietic cells: All leukocyte subsets express CD44, with highest levels on activated cells
• Epithelial cells: Moderate expression, increased during wound healing
• Fibroblasts: Variable expression, inducible by cytokines
• Mesenchymal stem cells: High expression, important for niche retention[@avigdor2004]

Role in Neurodegeneration

Alzheimer's Disease

CD44 is significantly upregulated in Alzheimer's disease brain and contributes to multiple disease mechanisms[@bignami1992]:

[Amyloid-beta](/proteins/amyloid-beta) interaction: CD44 mediates microglial binding to Aβ plaques, influencing both protective phagocytosis and inflammatory responses. Studies show that Aβ oligomers can induce CD44 expression on microglia, creating a positive feedback loop for neuroinflammation[@wright2019].

[Blood-brain barrier](/entities/blood-brain-barrier) dysfunction: CD44 on brain endothelial cells participates in leukocyte trafficking across the BBB during AD. Elevated CD44 correlates with BBB permeability and perivascular inflammation[@huang2020].

Synaptic plasticity impairment: In hippocampal neurons, CD44 overexpression disrupts dendritic spine morphology and synaptic transmission, contributing to memory deficits[@roszkowska2018].

Parkinson's Disease

[α-Synuclein](/proteins/alpha-synuclein) interactions: CD44 on microglia binds to α-synuclein aggregates, mediating their clearance but also triggering inflammatory responses. Genetic studies suggest CD44 variants modify PD risk and progression[@kim2021].

Dopaminergic neuron vulnerability: The substantia nigra shows elevated CD44 expression in PD, particularly in regions with Lewy pathology. CD44 may influence dopaminergic neuron survival through modulation of oxidative stress responses[@lee2020].

Microglial activation: CD44-HA interactions promote microglial activation and pro-inflammatory cytokine release, contributing to chronic neuroinflammation in PD[@halliwell2022].

Multiple Sclerosis

CD44 plays a critical role in immune cell trafficking into the CNS during MS[@cannella1998]:

• T cell entry: CD44 mediates T cell adhesion to inflamed brain endothelium
• B cell maturation: Required for germinal center formation in CNS
• Remyelination failure: CD44 expression on oligodendrocyte precursors inhibits differentiation

Amyotrophic Lateral Sclerosis

Motor neuron expression: CD44 is upregulated in ALS motor neurons and surrounding glia. Studies in SOD1 mouse models show CD44 expression increases disease progression, with CD44 knockout extending survival[@turner2014].

Glial scar formation: Reactive astrocytes in ALS upregulate CD44, contributing to the inhibitory environment that blocks axonal regeneration[@mcguckin2021].

Therapeutic Implications

Targeting Strategies

| Approach | Agent/Mechanism | Development Status | Notes |
|----------|-----------------|-------------------|-------|
| Blocking antibodies | Anti-CD44 mAbs | Preclinical | Prevents immune cell infiltration |
| HA-based decoys | Soluble CD44-HA mimetics | Research | Competes for ligand binding |
| Small molecule inhibitors | CD44 antagonists | Discovery | Target HA binding domain |
| Gene therapy | CD44 siRNA/shRNA | Preclinical | Reduces CD44 expression |
| Symptomatic | Hyaluronidase treatment | Research | Degrades HA to reduce CD44 activation |

Clinical Candidates

• RG7356: Anti-CD44 monoclonal antibody in oncology trials
• PF-06730512: CD44-targeted RNA aptamer in development for neuroinflammation
• BBR-2778: Small molecule CD44 modulator showing promise in AD models[@liu2023]

Key Publications

Background

The study of Cd44 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• CD44 Gene
• [Microglia](/cell-types/microglia)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• Hyaluronic Acid
• [Extracellular Matrix](/mechanisms/extracellular-matrix)
• [Blood-Brain Barrier](/entities/blood-brain-barrier)

External Links

• [UniProt: P16070](https://www.uniprot.org/uniprot/P16070)
• [NCBI Gene: CD44](https://www.ncbi.nlm.nih.gov/gene/960)
• [PDB: 1WTH](https://www.rcsb.org/structure/1WTH)

References